{"disease":{"id":"non-small-cell-lung-cancer-with-egfr-mutations-likely-primary-indication-based-on-drug-class.md","name":"non small cell lung cancer with egfr mutations likely primary indication based on drug class.md"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}